Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Cellegy Enters Deal With PDL For Marketing Of Tostrex Gel

Jan. 3, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

Transave Raises $12M For Work Targeting Diseases Of The Lung

Dec. 27, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...